Revenue (Tables)

12 Months Ended

Mar. 31, 2026

Revenue from Contract with Customer [Abstract]

Summary of Disaggregation of Revenue

Revenue is disaggregated as follows:


		Years ended
		March 31,				March 31,				March 31,
		2026				2025				2024
Cannabis
Canadian adult-use cannabis1		$	94,472			$	78,828			$	92,803
Canadian medical cannabis2			90,818				77,032				66,362
International markets cannabis			28,654				30,866				32,518
		$	213,944			$	186,726			$	191,683

Storz & Bickel		$	70,659			$	82,269			$	79,464
This Works			-				-				21,256
Other1,2			-				-				4,743
Net revenue		$	284,603			$	268,995			$	297,146

1 A reclassification of $433 of ancillary cannabis revenues from Other to Canadian adult-use cannabis occurred for the year ended March 31, 2024.

2 A reclassification of $5,016 of ancillary cannabis revenues from Other to Canadian medical cannabis occurred for the year ended March 31, 2024.

3 Canadian adult-use cannabis net revenue during the year ended March 31, 2026 reflects excise taxes of $51,856 (year ended March 31, 2025 - $36,442; and year ended March 31, 2024 - $40,115).

4 Canadian medical cannabis net revenue during the year ended March 31, 2026 reflects excise taxes of $10,368 (year ended March 31, 2025 - $8,532; and year ended March 31, 2024 - $6,673).